4th Conference on Retroviruses and
Opportunistic Infections Preliminary Program Update
| Opening
Session 6-8 pm |
Wednesday JANUARY 22, 1997 |
Bernard S. Fields Memorial Lecture Can HIV Be Eradicated from an Infected Person? DAVID HO Plenary
Lecture |
| Thursday JANUARY 23, 1997 |
Friday JANUARY 24, 1997 |
Saturday JANUARY 25, 1997 |
Sunday JANUARY 26, 1997 |
|
| State-of-the-Art Lectures (Plenaries) 8:30-9:15 am Please see times noted for the Sunday schedule |
2. Viral and Cellular Dynamics: Implications for Antiretroviral Therapy |
36. CMV | 73. NeuroAIDS | 85.
Perinatal Transmission and Early Virus Replication Events
in Babies 8-8:45 am |
| State-of-the-Art Lectures 9:15-10 am |
3. Chemokines: Structure and Biological Activities | 37.
Molecular Mechanisms in HIV Infection and Replication:
Results from X-ray Crystallography |
74. Transport In and Out of the Nucleus | 86. Transport of Antigens and Infectious Agent Across Mucosae 8:45-9:30 pm |
| Slide
Sessions 10:30 am- 12:30 pm |
4.
Opportunistic Infections: PCP, Fungi, Cryptosporidiosis,
PML and Dementia 5. Antiretroviral Chemotherapy: New Agents, Resistance, and in vitro Assessment Techniques 6. Pathogenesis I 7. Epidemiology: Virologic Aspects 8. Immunopatho- |
38.
Mycobacterial and Bacterial Opportunistic Infections;
Opportunistic Infection Correlations with Viral Load and
Survival 39. Antiviral Therapy: 40. Epidemiology: Trends and Prevention 41. Pathogenesis II 42. Molecular Virology I |
75. Antiviral Therapy:
Pediatric Clinical Trials, Viral Load in Genital
Secretions 76. HHV-8 (KSHV); Tissue Correlates of Opportunistic Infections 77. Molecular Virology II: Chemokine Receptors, nef, VPR 78. Pathogenesis III and Retroviral Diagnostics 79. Immune Response and |
87. Late
Breaker Session 9:45 am- 12:30 pm |
| Symposia 2-4 pm |
9. Pneumocystis
carinii: Clinical Insights from the Bench 10. HIV Entry Cofactors: The Chemokine receptor Connection 11. Non-KS Malignancies: Bench to Bedside 12. Advances in HIV Prevention |
43.Mycobacteria:
Bench to Bedside 44. Kaposi's Sarcoma/ KSHV 45. Vaccine Strategies 46. Primary/Early Events |
80.
Determinants of Disease Progression 81. Basic and Clinical Pharmacology of Protease Inhibitors 82. Intestinal Protozoa/ Cryptosporidium: Bench to Bedside 83. Role of Accessory and Regulatory Genes for Virus-cell Interactions |
|
| Posters and Special Symposium 4-6:30 pm |
Poster
Sessions 13-35 |
Poster Sessions 47-72 | 84. Symposium: Update on Antiretroviral Therapy |
© 4th Conference on
Retroviruses and Opportunistic Infections,
Foundation for Retrovirology and Human Health